After just 46 hours at room temperature, a significant portion of the semaglutide may lose potency, meaning you receive less active medication than your dose level indicates
Maintaining proper storage conditions is essential for ensuring the medication remains stable and suitable for use throughout its beyond-use date
Semaglutide, manufactured by Novo Nordisk, was approved by the FDA in August for treating MASH, but it is only one type of GLP-1 agonist receptor that could provide treatment options
3 Likes qBx123Yk April 14, 2026, 11:55pm #6 Pretty sure 85mg of ghk-cu exceeds the upper limit that would lead to copper toxicity for actual humans
Your specialist may suggest trying an alternative agent before abandoning the class entirely
If you have thyroid concerns, a history of pancreatitis, kidney disease, or take multiple medications that interact with semaglutide, the added oversight of traditional prescribing pathways provides meaningful safety benefits